Wellmark Blue Cross and Blue Shield announced late Wednesday that it will retroactively waive members’ cost-share related to the treatment of COVID-19 — including copays, coinsurance and deductibles — when seeking care from an in-network provider, effective Feb. 4 through at least June 16. This is in addition to Wellmark’s previous announcement on March 20 in which it eliminated cost-share payments for COVID-19 diagnostic testing and virtual visits as well as allowing early refills of prescriptions and reimbursing providers for telehealth visits. “We want to eliminate cost barriers for our members to get care for COVID-19,” said Cory Harris, Wellmark’s president and chief operating officer. “Additionally, we are making this retroactive to care as soon as COVID-19 medical codes were made available.” The changes apply to all Wellmark fully insured and Medicare Supplement members. Wellmark will work with self-funded groups that want to implement similar benefits for their members. UnitedHealthcare has also announced it will waive member cost-sharing for the treatment of COVID-19 through May 31 for its fully insured commercial, Medicare Advantage and Medicaid plans, and said it will work with self-funded customers who want the insurer to implement a similar approach on their behalf.